(Reuters) -Johnson & Johnson is in discussions to buy Protagonist Therapeutics, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Shares of Protagonist were up 9.4% in morning trade.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D’Silva)
(Reuters) -Johnson & Johnson is in discussions to buy Protagonist Therapeutics, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Shares of Protagonist were up 9.4% in morning trade.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D’Silva)
